Among the many promising advances in breast cancer treatment in recent years are CDK4/6 inhibitors. These are targeted drugs that can be used for women with a common type of breast cancer: hormone receptor-positive and HER2-negative.
Currently, there are three CDK4/6 inhibitors approved to treat…
